[Estimating ability of dihydroquercetin to inhibit oxidation of fibrinogen by ozone].

[Estimating ability of dihydroquercetin to inhibit oxidation of fibrinogen by ozone].

Eksperimental'naia i klinicheskaia farmakologiia (2013-06-19)

V S Rogovskiĭ, M A Rozenfel'd, S D Razumovskiĭ, A I Matiushin, N L Shimanovskiĭ, B V Leonova, M L Konstantinova

ZUSAMMENFASSUNG

The ability of dihydroquercetin to inhibit the oxidation of fibrinogen has been evaluated. It is established that dihydroquercetin inhibits oxidation of fibrinogen by ozone, thus preventing oxidative modification of fibrinogen and preserving its functional activity.

MATERIALIEN

Produktnummer

Marke

Produktbeschreibung

F8630

Sigma-Aldrich

Fibrinogen aus Rinderplasma, Type I-S, 65-85% protein (≥75% of protein is clottable)

F3879

Sigma-Aldrich

Fibrinogen aus Humanplasma, 50-70% protein (≥80% of protein is clottable)

F4883

Sigma-Aldrich

Fibrinogen aus Humanplasma, 35-65% protein (≥90% of protein is clottable).

F6755

Sigma-Aldrich

Fibrinogen from rat plasma, 60-80% protein (≥60% of protein is clottable)

78666

Supelco

Taxifolin, analytical standard